D
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A61.2 KBDova Pharmaceuticals Inc.Nov 15, 6:05 PM ET·0001193125-19-293583
- 8-K96.9 KBDova Pharmaceuticals Inc.Nov 12, 9:25 AM ET·0000950157-19-001299
- 10-Q5.7 MBDova Pharmaceuticals Inc.Nov 12, 6:05 AM ET·0001685071-19-000029
- 8-K928.1 KBDova Pharmaceuticals Inc.Oct 3, 4:06 PM ET·0001104659-19-052965
- 8-K60.1 KBDova Pharmaceuticals Inc.Sep 30, 6:09 AM ET·0001104659-19-051883
- 10-Q4.6 MBDova Pharmaceuticals Inc.Aug 6, 7:14 AM ET·0001685071-19-000023
- 8-K181.5 KBDova Pharmaceuticals Inc.Aug 6, 7:07 AM ET·0001685071-19-000022
- 8-K161.1 KBDova Pharmaceuticals Inc.Jun 27, 8:29 AM ET·0001685071-19-000018
- 10-Q4.5 MBDova Pharmaceuticals Inc.May 7, 7:16 AM ET·0001685071-19-000015
- 8-K137.1 KBDova Pharmaceuticals Inc.May 7, 7:12 AM ET·0001685071-19-000014
Insiders
10- ALLEN LEE F MD PhDChief Medical Officer
- BLANKENSHIP DOUGLASChief Financial Officer
- EDELMAN JOSEPH10% Owner
- Goldman Steven M.Director
- Hahn Mark WChief Financial Officer
- Hoitt JasonChief Commercial Officer
- JEFFS ROGERDirector
- Laliberte KevinSr. VP, Product Development
- Manning Paul BDirector, 10% Owner
- Novak Alfred JDirector
Tickers
No tickers on record
Addresses
business
240 LEIGH FARM ROAD
DURHAM, NC, 27707
mailing
240 LEIGH FARM ROAD
DURHAM, NC, 27707
Former Names
- Dova Pharmaceuticals, Inc.2018-10-04